Zobrazeno 1 - 10
of 359
pro vyhledávání: '"Tandon Bn"'
Autor:
Tandon Bn, Yogesh Chawla, Mohan D Gupte, Rohit Goyal, Divya Seth, Shakti Kumar, Subrat K. Acharya, S. M. Gupta, V Sreenivas, Premashish Kar, A Tandon, Vidya A. Arankalle, Aejaz Habeeb, Siddharth Datta Gupta, Deepak Amarapurkar, Gourdas Choudhuri, Shiv Kumar Sarin, Abhijit Chowdhury, Deepali Mukherjee
Publikováno v:
Journal of Clinical and Experimental Hepatology. 2:10-18
Background and Aim: Pegylated-interferon-alfa (PEG-IFN-a) with ribavirin is an established treatment in chronic hepatitis due to hepatitis C virus (HCV) (CH-C). Such treatment is expensive and in resource-poor countries such as India, alternative les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1852a9fd0cbd86b3d62bed9a190a94
https://doi.org/10.1016/s0973-6883(12)60079-6
https://doi.org/10.1016/s0973-6883(12)60079-6
Autor:
Vishnubhatla Sreenivas, A Tandon, S. Duttagupta, Mohammad Irshad, Santosh Kumar Nanda, Yogendra Kumar Joshi, Subrat Kumar Panda, T. L. Kumer, Rakesh K. Tandon, Subrat K. Acharya, S. Sushma, S. Nijhawan, Tandon Bn, Srinivasan Dasarathy, K. S. U. Prasanna
Publikováno v:
Hepatology. 23:1448-1455
The profiles of patients with fulminant hepatic failure (FHF) from developing countries have not been reported earlier. The current study was conducted prospectively, at a single tertiary care center in India, to document the demographic and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51673b5df05f1585be50d6d81cc7027
https://doi.org/10.1002/hep.510230622
https://doi.org/10.1002/hep.510230622
Publikováno v:
Journal of Gastroenterology and Hepatology. 9:355-360
The present study describes the plasma levels of soluble fibronectin (FN), C3d, the breakdown product of C3 complement and Ba, the breakdown product of properdin factor B, in 30 patients of uncomplicated acute viral hepatitis (AVH), 64 patients of fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a072f38f8a8ccb876047a161fc83cfe
https://doi.org/10.1111/j.1440-1746.1994.tb01255.x
https://doi.org/10.1111/j.1440-1746.1994.tb01255.x
Publikováno v:
Journal of Clinical Gastroenterology. 14:31-35
Surgicalorty patients with cirrhosis of the liver and tense ascites were randomized to receive either aldactone 400 mg/day and furosemid 80 mg/day (n = 20) or repeated large volume paracentesis (LVP) and infusion of low molecular weight dextran (n =
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4ed2b93ffef8a276a64101b1575003
https://doi.org/10.1097/00004836-199201000-00008
https://doi.org/10.1097/00004836-199201000-00008
Publikováno v:
Gastroenterologia Japonica. 26:62-65
A controlled randomized study and a subsequent prospective therapeutic trial have demonstrated the efficacy of an intensive therapy comprising hourly intravenous injections of 100 mg of cimetidine along with a continuous nasogastric infusion of a liq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01a79ddce18e67ff67f9b20cd2363bf
https://doi.org/10.1007/bf02779265
https://doi.org/10.1007/bf02779265
Publikováno v:
Gastroenterologia Japonica. 26:192-195
The present study describes the status of hepatitis C virus infection in 167 patients with severe forms of liver diseases in India. The anti-HCV positivity rate was recorded as 43%, 47%, and 42% in patients with FHF, SAHF, and CAH respectively. HBV a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8083e4e904142c64a26f5047e73c36c4
https://doi.org/10.1007/bf02779297
https://doi.org/10.1007/bf02779297
Publikováno v:
Journal of Gastroenterology and Hepatology. 5:608-615
Macaca mulatta monkeys have been used for the transmission of enteric non-A, non-B hepatitis (HEV) virus by intraportal route. Subsequent passages of HEV virus have been completed in these monkeys. In the first passage, 2 monkeys were inoculated by i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c305a794bf9ac16290939c3ddb1707c3
https://doi.org/10.1111/j.1440-1746.1990.tb01114.x
https://doi.org/10.1111/j.1440-1746.1990.tb01114.x
Publikováno v:
Gastroenterologia Japonica. 25:258-264
One hundred and seventy five subjects with chronic liver diseases which included patients with chronic active hepatitis (90), liver cirrhosis (31) and asymptomatic hepatitis B carriers (54), were included in the study. Hepatitis B virus (HBV) specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad49bee3d02da70bd5ea0d8abaf5644a
https://doi.org/10.1007/bf02776826
https://doi.org/10.1007/bf02776826
Publikováno v:
Gastroenterologia Japonica. 25:499-502
Anti-pre-S antibody was tested in 38 sera from patients with fulminant hepatitis (positive for HBsAg and/or IgM anti-HBc) using a specific solid phase enzyme linked immunosorbent assay (ELISA). Anti-pre-S activity was detected in 50 percent sera samp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7fc2e0da49412d05e529b72ed67b92
https://doi.org/10.1007/bf02779341
https://doi.org/10.1007/bf02779341
Publikováno v:
Journal of Gastroenterology and Hepatology. 5:288-295
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff867545477198ee1273e1092b2bcfe4
https://doi.org/10.1111/j.1440-1746.1990.tb01631.x
https://doi.org/10.1111/j.1440-1746.1990.tb01631.x